NZ Haematology Research Review Issue 20

In this issue:

Diagnostic value of immunoassays for HIT
Caplacizumab for acquired  thrombotic thrombocytopenic purpura
Validation of IMPROVE bleeding risk score
Hydroxyurea resistance/ intolerance in polycythaemia vera
ACCP VTE guideline update
Rituximab in elderly patients with resistant warm AIHA
PTS after CDT for DVT
Managing pruritus in primary myelofibrosis
Hospital heparin avoidance programme reduces HIT
VTE risk with breast cancer treatments

Please login below to download this issue (PDF)

Subscribe